Literature DB >> 10456346

Bone densities in patients receiving isotretinoin for cystic acne.

S A Leachman1, K L Insogna, L Katz, A Ellison, L M Milstone.   

Abstract

BACKGROUND: Few studies have been done of bone densities in humans receiving retinoids, despite a substantial amount of literature concerning retinoid-induced osteoporosis in animals. We prospectively measured bone density and calcium metabolism in young men (aged 17-25 years) receiving oral isotretinoin for cystic acne and in a group of healthy volunteers (aged 19-26 years). OBSERVATIONS: Compared with that in healthy control subjects, mean bone density was lower at all sites (spine, femoral neck, and Ward triangle) and was considerably more variable at the spine in young men with cystic acne even before treatment. Bone density at the Ward triangle decreased a mean of 4.4% (P = .03) after 6 months of isotretinoin use (1 mg/kg of body weight). Four patients showed decreased density of more than 9% at the Ward triangle. The difference between the mean change in bone density in the patient group and in the control group was significant at the Ward triangle (P = .04) but not at the other sites. Measurements of calcium metabolism did not change over time in either group.
CONCLUSIONS: A loss of bone density occurring in the absence of measurable alterations of calcium metabolism is likely to be a direct effect of retinoids on bone. Further study of retinoid-induced osteoporosis in humans and of bone density in patients with cystic acne is needed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456346     DOI: 10.1001/archderm.135.8.961

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  A hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria.

Authors:  Ozden Ozyemisci-Taskiran; Nesrin Bölükbasi; Feride Gögüs
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

2.  The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions.

Authors:  James J Leyden; James Q Del Rosso; Eric W Baum
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

3.  Isotretinoin and FoxO1: A scientific hypothesis.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2011-07-01

4.  Isotretinoin effect on alveolar repair after exodontia--a study in rats.

Authors:  Roberta Dalmolin Bergoli; Otacilio Luiz Chagas Junior; Carlos Eduardo Chrzanowski Pereira de Souza; Beatriz Farias Vogt; Henrique Telles Ramos de Oliveira; Adriana Etges; Daniela Nascimento Silva
Journal:  Oral Maxillofac Surg       Date:  2010-07-25

5.  A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.

Authors:  K B Hoover; C G Miller; N C Galante; C B Langman
Journal:  Osteoporos Int       Date:  2015-05-09       Impact factor: 4.507

Review 6.  Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis.

Authors:  Jan Kapała; Julia Lewandowska; Waldemar Placek; Agnieszka Owczarczyk-Saczonek
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

7.  Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy.

Authors:  Ayçe Atalay; Asli Altaykan; Gül Ergin; Yeşim Gökçe Kutsal
Journal:  Rheumatol Int       Date:  2003-09-10       Impact factor: 2.631

Review 8.  A review of diagnosis and treatment of acne in adult female patients.

Authors:  A U Tan; B J Schlosser; A S Paller
Journal:  Int J Womens Dermatol       Date:  2017-12-23

Review 9.  The safety of isotretinoin treatment in patients with bone fractures.

Authors:  Bartosz Miziołek; Beata Bergler-Czop; Anna Stańkowska; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

10.  Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.

Authors:  Andrea L Zaenglein; Moise L Levy; Nicole S Stefanko; Latanya T Benjamin; Anna L Bruckner; Keith Choate; Brittany G Craiglow; John J DiGiovanna; Lawrence F Eichenfield; Peter Elias; Philip Fleckman; Leslie P Lawley; Richard A Lewis; Anne W Lucky; Erin F Mathes; Leonard M Milstone; Amy S Paller; Sonali S Patel; Dawn H Siegel; Joyce Teng; Sherry A Tanumihardjo; Lauren Thaxton; Mary L Williams
Journal:  Pediatr Dermatol       Date:  2020-11-10       Impact factor: 1.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.